1990
DOI: 10.1080/00032719008052559
|View full text |Cite
|
Sign up to set email alerts
|

Derivative Spectrophotometric Determination of Levodopa and Benserazide Hydrochloride

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

1995
1995
2008
2008

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 19 publications
(8 citation statements)
references
References 15 publications
0
8
0
Order By: Relevance
“…When KMnO 4 concentration was increased from 1.0 × 10 −4 to 0.5 × 10 -3 mol/L, the CL signal increased slowly. This might be attributed to subsequent destruction of the formed emitter by excess KMnO 4 or to the absorption of the emission by excess KMnO 4 . Therefore, 0.5 × 10 -3 mol/L KMnO 4 was chosen for subsequent experiments.…”
Section: Selection Of Potassium Permanganate Concentrationmentioning
confidence: 94%
See 2 more Smart Citations
“…When KMnO 4 concentration was increased from 1.0 × 10 −4 to 0.5 × 10 -3 mol/L, the CL signal increased slowly. This might be attributed to subsequent destruction of the formed emitter by excess KMnO 4 or to the absorption of the emission by excess KMnO 4 . Therefore, 0.5 × 10 -3 mol/L KMnO 4 was chosen for subsequent experiments.…”
Section: Selection Of Potassium Permanganate Concentrationmentioning
confidence: 94%
“…Several techniques have been reported in the literature for the determination of laevodopa, such as spectrofluorimetry (3), spectrophotometry (3)(4)(5)(6)(7)(8), ion-selective electrode (9), NMR spectroscopy (10), flow-injection analysis (FIA) (11)(12)(13)(14), and high-performance liquid chromatography (HPLC) (15)(16)(17). To our knowledge, there have been a few reports for the determination of laevodopa based on a chemiluminescence (CL) analysis system.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is used in the treatment of Parkinson's disease, usually associated with a peripheral aromatic-l-amino acid decarboxylase (AADC) inhibitor, such as benserazide [N -(2,3,4-trihydroxybenzyl)-d,l-serine], in order to increment the proportion that enters the brain [1,2]. Scientific literature reports several methods for the determination of levodopa and benserazide in pharmaceutical preparations and in biological fluids, such as spectrophotometry [3][4][5][6][7][8][9], capillary zone electrophoresis [10,11], high performance liquid chromatography [12][13][14][15] and gas chromatography [16]. Flow injection analysis (FIA) has been applied to the determination of levodopa in mixtures with other drugs [17] and of benserazide in tablets [18].…”
Section: Introductionmentioning
confidence: 99%
“…Due to the chemical similarity of the two compounds, simultaneous determination was achieved using differential spectrophotometry, 2 derivative spectrophotometry [3][4][5] and kineticspectrophotometric methods. 6,7 Capillary electrophoresis (CE) with spectrophotometric 8,9 and amperometric detection 10 was also used for simultaneous determination of these drugs.…”
Section: Introductionmentioning
confidence: 99%